USANA HEALTH SCIENCES INC

For the period ended Mar 30, 2024. Filed May 7, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 30, 2024 · Filed May 7, 2024

USNA$13.10-5.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Stockholders’ Equity

(in thousands)

For three months ended April 1, 2023

Common Stock · AdditionalPaid-inCapital · RetainedEarnings · AccumulatedOtherComprehensiveIncome (Loss) · Total
Shares · Value
Balance at December 31, 2022	19,206	$19		$55,604		$391,636	$(12,787)	$434,472
Net earnings					18,383		18,383
Other comprehensive income (loss), net of tax						1,752	1,752
Equity-based compensation expense			3,608				3,608
Common stock issued under equity award plans	88	—					—
Tax withholding for net-share settled equity awards			(2,861)				(2,861)
Balance at April 1, 2023	19,294	$19		$56,351		$410,019	$(11,035)	$455,354

For three months ended March 30, 2024

Common Stock · AdditionalPaid-inCapital · RetainedEarnings · AccumulatedOtherComprehensiveIncome (Loss) · Total
Shares · Value
Balance at December 30, 2023	19,130	$19		$65,661		$445,217	$(13,695)		$497,202
Net earnings					16,537		16,537
Other comprehensive income (loss), net of tax						(4,898)	(4,898)
Equity-based compensation expense			3,669				3,669
Common stock repurchased and retired	(194)	—		(1,180)		(8,303)		(9,483)
Common stock issued under equity award plans	111	—					—
Tax withholding for net-share settled equity awards			(3,039)				(3,039)
Balance at March 30, 2024	19,047	$19		$65,111		$453,451	$(18,593)		$499,988

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.